Firefly Neuroscience has formed a strategic partnership with the Neurology Consultants of Dallas (NCD) to help enhance early detection efforts and disease management for patients suffering from cognitive decline. NCD will incorporate Firefly’s Brain Network Analytics (BNA) technology into its patient workflow and conduct clinical studies aimed at identifying biomarkers for predicting the onset of dementia that can potentially optimize patient care pathways. By establishing a baseline for every patient, healthcare providers can more accurately track cognitive changes, which will promote the early detection and effective management of cognitive decline.

Read Article